Fiduciary Management Inc. WI Purchases 1,339,055 Shares of Koninklijke Philips N.V. $PHG

Key Points

• Fiduciary Management Inc. WI increased its stake in Koninklijke Philips N.V. by 21.7% during the first quarter, now owning approximately 7.5 million shares, valued at about $190.9 million.
• Multiple hedge funds have also bought or increased their stakes in Koninklijke Philips, indicating a positive interest among institutional investors, with 13.67% of the stock currently owned by them.
• Analyst ratings for Koninklijke Philips vary, with one downgrade to a "hold" rating, but the overall consensus remains a "buy" according to the latest data from MarketBeat.

Fiduciary Management Inc. WI raised its position in Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 21.7% during the first quarter, according to its most recent filing with the SEC. The firm owned 7,515,737 shares of the technology company's stock after purchasing an additional 1,339,055 shares during the period. Koninklijke Philips accounts for approximately 1.8% of Fiduciary Management Inc. WI's portfolio, making the stock its 19th largest position. Fiduciary Management Inc. WI owned 0.80% of Koninklijke Philips worth $190,900,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of PHG. QRG Capital Management Inc. lifted its holdings in Koninklijke Philips by 11.0% in the first quarter. QRG Capital Management Inc. now owns 142,595 shares of the technology company's stock valued at $3,622,000 after buying an additional 14,090 shares during the period. Aurora Private Wealth Inc. bought a new position in shares of Koninklijke Philips in the 1st quarter worth about $1,695,000. Quantinno Capital Management LP lifted its stake in shares of Koninklijke Philips by 71.1% in the 4th quarter. Quantinno Capital Management LP now owns 180,149 shares of the technology company's stock valued at $4,561,000 after purchasing an additional 74,835 shares during the period. Cerity Partners LLC increased its holdings in Koninklijke Philips by 30.6% in the first quarter. Cerity Partners LLC now owns 80,767 shares of the technology company's stock worth $2,051,000 after purchasing an additional 18,906 shares in the last quarter. Finally, HB Wealth Management LLC bought a new position in shares of Koninklijke Philips during the 1st quarter worth approximately $333,000. 13.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Wall Street Zen downgraded shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy".

Koninklijke Philips Stock Down 0.6%

NYSE:PHG traded down $0.16 during trading hours on Wednesday, hitting $27.65. 276,211 shares of the company traded hands, compared to its average volume of 985,298. Koninklijke Philips N.V. has a one year low of $21.48 and a one year high of $32.91. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.69. The company has a market cap of $26.62 billion, a PE ratio of 145.45, a PEG ratio of 0.75 and a beta of 0.75. The firm's 50-day simple moving average is $25.43 and its 200-day simple moving average is $25.01.

Koninklijke Philips (NYSE:PHG - Get Free Report) last announced its earnings results on Tuesday, July 29th. The technology company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.29 by $0.12. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. The company had revenue of $5.05 billion during the quarter, compared to the consensus estimate of $4.35 billion. Equities analysts predict that Koninklijke Philips N.V. will post 1.63 earnings per share for the current year.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.